List view / Grid view

Webinars

High content screening reveals the phenotypic landscape of intestinal organoid regeneration

ON-DEMAND By Yokogawa Life Innovations

Watch our on-demand webinar and learn how image-based phenotypic screening relies on extraction of multivariate information from cells cultured in a large number of screened conditions. In this webinar, we explore the application of complex and biologically relevant model systems for drug screening, such as small intestinal organoids.

New methods towards efficient and high-throughput drug-target screening

ON-DEMAND By Living Systems Institute, University of Exeter

Watch our on-demand webinar where we explore new methods to improve data quality from high-throughput screens. You'll learn about solutions for common problems in drug-target discovery and our keynote speaker will also look at case studies where new approaches to screening have identified high-quality candidate drugs for proliferative diseases.

SARS-CoV-2 testing: automation of high-throughput qPCR and COVID-seq

ON-DEMAND By SPT Labtech

In this on-demand webinar, we explored the various methods of COVID-19 testing: qPCR, COVID-seq, antigen and antibody detection, and others. Coupling these assays with low volume, high speed automation has made great strides toward achieving the high-throughput testing essential to ending this pandemic.

Mobile phase optimisation for oligonucleotide analytical methods by LC-MS

ON-DEMAND By Phenomenex

In this on-demand webinar, we provide an overview of nucleic acid therapeutics and discuss the chromatographic challenges associated with oligonucleotides. We also explore modulation of the mobile phase additives alkylamine ion pair and perfluorinated alcohols. Finally, we will show how optimisation of mobile phase can improve not only chromatographic performance…

Cell-based Surface Plasmon Resonance with AstraZeneca

ON-DEMAND By Biosensing Instrument

In this webinar, we will provide an overview of the technology with some application examples and also see a case study how AstraZeneca is exploring SPRM for studies on G-protein-coupled receptors (GPCR) in close collaboration with Biosensing Instrument.